SEC Form 4 · accession 0001209191-16-109800
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Mar 17, 2016
Accepted (ET)
Mar 21, 2016 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.99 | Mar 17, 2016 | A | 22,000 | A | — | Mar 17, 2026 | Common Stock | 22,000 | 22,000 | D |
Explanation of responses
- F1The shares underlying this option will vest and become exercisable in three equal installments on March 17, 2017, 2018 and 2019, subject to the reporting person's continuous service as of each such vesting date.